2010
DOI: 10.1073/pnas.0908526107
|View full text |Cite
|
Sign up to set email alerts
|

Structural basis for the cooperative interplay between the two causative gene products of combined factor V and factor VIII deficiency

Abstract: Combined deficiency of coagulation factors V and VIII (F5F8D), an autosomal recessive disorder characterized by coordinate reduction in the plasma levels of factor V (FV) and factor VIII (FVIII), is genetically linked to mutations in the transmembrane lectin ERGIC-53 and the soluble calcium-binding protein MCFD2. Growing evidence indicates that these two proteins form a complex recycling between the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment and thereby function as a cargo receptor in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
51
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 46 publications
(55 citation statements)
references
References 40 publications
3
51
1
Order By: Relevance
“…68,69 LMAN1 binds these 2 clotting factors through its CRD, while MCFD2 binds them through the EF-hand domains. LMAN1 and MCFD2 also interact with each other through CRD and EF-hand motifs 70,71 ; however, the specific sites of interaction are distinct from the binding sites for FV and FVIII. LMAN1-deficient mice demonstrate decreased FV and FVIII levels (ϳ 50% of normal), and slightly distended ER with accumulation of ␣1-antitrypsin in hepatocytes, though ␣1-antitrypsin plasma levels are not reduced.…”
Section: Pathogenesis Of F5f8dmentioning
confidence: 99%
“…68,69 LMAN1 binds these 2 clotting factors through its CRD, while MCFD2 binds them through the EF-hand domains. LMAN1 and MCFD2 also interact with each other through CRD and EF-hand motifs 70,71 ; however, the specific sites of interaction are distinct from the binding sites for FV and FVIII. LMAN1-deficient mice demonstrate decreased FV and FVIII levels (ϳ 50% of normal), and slightly distended ER with accumulation of ␣1-antitrypsin in hepatocytes, though ␣1-antitrypsin plasma levels are not reduced.…”
Section: Pathogenesis Of F5f8dmentioning
confidence: 99%
“…The sedimentation velocity experiments were performed in buffer D using a Proteomelab XL-1 Analytical Ultracentrifuge (Beckman-Coulter, Fullerton, CA) by a previously reported method. 52,53) A 390-mL portion of -Gal-A at a concentration of 0.56 mM, 2.8 mM, or 5.6 mM was sedimented at 35,000 rpm at 20 C using 12-mm charcoal-filled double sector centerpieces with quartz windows, while -Gal-C (0.9 mM, 1.9 mM, and 7.4 mM) was sedimented at 40,000 rpm. Sedimentation behavior was monitored with absorbance detection optics, and all the sedimentation velocity data were analyzed by the continuous sedimentation coefficient distribution cðsÞ model included in the SEDFIT11.71 software program.…”
Section: Materials Biolactamentioning
confidence: 99%
“…Therefore, these results imply that ␤1 is directly involved in MCFD2 binding, consistent with the crystal structures of the CRD-MCFD2 complex. 18,19 To identify critical amino acid residues in the ␤1 region that are involved in MCFD2 binding, we developed a model of the LMAN1-MCFD2 complex using molecular docking methods (detailed methods and results in supplemental Document 1) from the nuclear magnetic resonance structure of MCFD2 (PDB code: 2VRG) 33 and a homology model of the human CRD (supplemental Figure 1A), based on the crystal structure of the rat CRD (PDB code: 1R1Z). 30,31 In this model, the N-terminus of the CRD (primarily ␤1) directly contacts MCFD2 (supplemental Figure 2).…”
Section: Mcfd2 Interacts With the N-terminus Of Lman1mentioning
confidence: 99%
“…15 MCFD2 can interact with FV and FVIII independent of LMAN1 and the EF hand domains of MCFD2 are sufficient for binding both LMAN1 and FV/FVIII. 6,7 During the preparation of this manuscript, crystal structures of the CRD-MCFD2 complex were published, 18,19 which identify the binding surface consisting of the EF hand domain of MCFD2 and the N-terminal side of the CRD. Most MCFD2 missense mutations either disrupt the protein structure or change a crucial amino acid residue involved in binding the CRD.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation